PE20011188A1 - El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos - Google Patents
El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferosInfo
- Publication number
- PE20011188A1 PE20011188A1 PE2001000364A PE2001000364A PE20011188A1 PE 20011188 A1 PE20011188 A1 PE 20011188A1 PE 2001000364 A PE2001000364 A PE 2001000364A PE 2001000364 A PE2001000364 A PE 2001000364A PE 20011188 A1 PE20011188 A1 PE 20011188A1
- Authority
- PE
- Peru
- Prior art keywords
- bacterial
- composition
- azalides
- antibiotics
- mammals
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 208000035143 Bacterial infection Diseases 0.000 title abstract 2
- 230000001580 bacterial effect Effects 0.000 title abstract 2
- 208000022362 bacterial infectious disease Diseases 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 title 1
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 229940088710 antibiotic agent Drugs 0.000 title 1
- 208000028172 protozoa infectious disease Diseases 0.000 title 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 3
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 abstract 2
- KFZMGEQAYNKOFK-YZRHJBSPSA-N (214C)propan-2-ol Chemical compound [14CH](C)(C)O KFZMGEQAYNKOFK-YZRHJBSPSA-N 0.000 abstract 1
- LFQSCWFLJHTTHZ-HQMMCQRPSA-N Ethanol-14C Chemical compound C[14CH2]O LFQSCWFLJHTTHZ-HQMMCQRPSA-N 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract 1
- 206010037075 Protozoal infections Diseases 0.000 abstract 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 229960000686 benzalkonium chloride Drugs 0.000 abstract 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 abstract 1
- 229960003872 benzethonium Drugs 0.000 abstract 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 abstract 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 abstract 1
- 229960003742 phenol Drugs 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 235000015424 sodium Nutrition 0.000 abstract 1
- 239000004289 sodium hydrogen sulphite Substances 0.000 abstract 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 abstract 1
- 235000010265 sodium sulphite Nutrition 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
SE REFIERE A UNA COMPOSICION QUE COMPRENDE: a) COMPUESTOS AZALIDOS DE FORMULA I Y II DONDE R ES H, ALQUILO C1-C10, CICLOALQUILO C3-C7, DONDE AMBOS GRUPOS R SON IDENTICOS Y b) UN VEHICULO FARMACEUTICAMENTE ACEPTABLE TAL COMO: i) AGUA; ii) ACIDOS EN UNA CONCENTRACION TOTAL DE 0,2 mmol A 1,0 mmol POR ml DE LA MEZCLA TAL COMO ACIDO ACETICO, ACIDO BENCENO SULFONICO, ACIDO CITRICO ENTRE OTROS; iii) CODISOLVENTES MISCIBLES CON AGUA EN UNA CANTIDAD DE 250mg A 750mg POR ml DE LA COMPOSICION TAL COMO ETANOL, ISOPROPANOL, PROPILENGLICOL, ENTRE OTROS; iv) DE 0,01mg A 10mg/ml DE ANTIOXIDANTE TAL COMO BISULFITO DE SODIO, SULFITO DE SODIO, TIOSULFATO DE SODIO, MONOTIOGLICEROL, ENTRE OTROS; v) DE 0,01mg A 10 mg/ml DE UN CONSERVANTE TAL COMO CLORURO DE BENZALCONIO, CLORURO DE BENZETONIO, FENOL, ENTRE OTROS. LA COMPOSICION ES UTIL PARA EL TRATAMIENTO DE INFECCIONES BACTERIANAS O PROTOZOARIA
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19996100P | 2000-04-27 | 2000-04-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20011188A1 true PE20011188A1 (es) | 2001-11-24 |
Family
ID=22739732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2001000364A PE20011188A1 (es) | 2000-04-27 | 2001-04-24 | El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US20020019353A1 (es) |
| EP (1) | EP1276747A1 (es) |
| JP (1) | JP2004516233A (es) |
| KR (1) | KR20030031479A (es) |
| CN (1) | CN1227258C (es) |
| AP (1) | AP2002002652A0 (es) |
| AR (1) | AR028041A1 (es) |
| AU (1) | AU4269301A (es) |
| BG (1) | BG107168A (es) |
| BR (1) | BR0110382A (es) |
| CA (1) | CA2407448A1 (es) |
| CZ (1) | CZ20023409A3 (es) |
| EA (1) | EA200200995A1 (es) |
| GT (1) | GT200100063A (es) |
| HU (1) | HUP0300585A3 (es) |
| IL (1) | IL152421A0 (es) |
| IS (1) | IS6559A (es) |
| MA (1) | MA26896A1 (es) |
| MX (1) | MXPA02010586A (es) |
| NO (1) | NO20025134L (es) |
| OA (1) | OA12257A (es) |
| PA (1) | PA8515601A1 (es) |
| PE (1) | PE20011188A1 (es) |
| PL (1) | PL359861A1 (es) |
| SK (1) | SK14882002A3 (es) |
| TN (1) | TNSN01063A1 (es) |
| UY (1) | UY26678A1 (es) |
| WO (1) | WO2001081358A1 (es) |
| YU (1) | YU78702A (es) |
| ZA (1) | ZA200208603B (es) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003040782A (ja) * | 2001-05-31 | 2003-02-13 | Pfizer Prod Inc | アザリド抗生物質組成物 |
| AU2002317415A1 (en) * | 2001-08-01 | 2003-02-17 | Pfizer Products Inc. | Azalide antibiotic compositions |
| US20060073172A1 (en) * | 2004-10-01 | 2006-04-06 | Schneider L W | Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure |
| DE102006010642A1 (de) * | 2006-03-08 | 2007-09-27 | Bayer Healthcare Aktiengesellschaft | Arzneimittelformulierungen, enthaltend Fluorchinolone |
| WO2009006466A1 (en) * | 2007-07-02 | 2009-01-08 | Novus International Inc. | Feeding regime for prevention of porcine enteropathic conditions |
| US8314071B2 (en) | 2007-12-21 | 2012-11-20 | Massachusetts Institute Of Technology | Bioactive molecules from co-cultivation of microbes |
| JP6441794B2 (ja) * | 2012-06-27 | 2018-12-19 | ケミン、インダストリーズ、インコーポレーテッドＫｅｍｉｎ Ｉｎｄｕｓｔｒｉｅｓ， Ｉｎｃ． | 抗コクシジウム活性を有する植物部分および抽出物 |
| US10568923B2 (en) * | 2012-06-27 | 2020-02-25 | Kemin Industries, Inc. | Plant parts and extracts having anticoccidial activity |
| US20180168196A1 (en) | 2016-12-15 | 2018-06-21 | Nestec Sa | Compositions and methods that modulate bacteria in a companion animal |
| CN106905396A (zh) * | 2017-02-21 | 2017-06-30 | 西南大学 | 富马酸替米考星复盐的制备方法 |
| CN106749458A (zh) * | 2017-02-21 | 2017-05-31 | 西南大学 | 苹果酸替米考星复盐的制备方法 |
| CN106905395A (zh) * | 2017-02-21 | 2017-06-30 | 西南大学 | 丁二酸替米考星复盐的制备方法 |
| AU2018225390B2 (en) * | 2017-02-22 | 2021-07-22 | ISR Immune System Regulation Holding AB (publ) | Novel immune stimulating macrolides |
| CA3120148A1 (en) * | 2018-11-19 | 2020-05-28 | Zikani Therapeutics, Inc. | C10-alkylene substituted 13-membered macrolides and uses thereof |
| CN109535211B (zh) * | 2018-12-19 | 2020-05-08 | 江苏威凌生化科技有限公司 | 一种合成纯化泰拉霉素杂质c的方法 |
| WO2023038852A1 (en) * | 2021-09-07 | 2023-03-16 | Zoetis Services Llc | Immunomodulating azalides |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698155A (en) * | 1991-05-31 | 1997-12-16 | Gs Technologies, Inc. | Method for the manufacture of pharmaceutical cellulose capsules |
| HN1998000086A (es) * | 1997-06-11 | 1999-03-08 | Pfizer Prod Inc | Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos. |
| US6239112B1 (en) * | 1998-07-09 | 2001-05-29 | Merial, Inc. | Water miscible macrolide solutions |
| US6100240A (en) * | 1998-10-09 | 2000-08-08 | Pfizer Inc | Macrolide derivatives |
| UA70972C2 (uk) * | 1998-11-20 | 2004-11-15 | Пфайзер Продактс Інк. | 13-членні азаліди і їх застосування як антибіотиків |
-
2001
- 2001-03-26 HU HU0300585A patent/HUP0300585A3/hu unknown
- 2001-03-26 IL IL15242101A patent/IL152421A0/xx unknown
- 2001-03-26 BR BR0110382-2A patent/BR0110382A/pt not_active IP Right Cessation
- 2001-03-26 AP APAP/P/2002/002652A patent/AP2002002652A0/en unknown
- 2001-03-26 EP EP01915612A patent/EP1276747A1/en not_active Withdrawn
- 2001-03-26 AU AU42693/01A patent/AU4269301A/en not_active Abandoned
- 2001-03-26 YU YU78702A patent/YU78702A/sh unknown
- 2001-03-26 OA OA1200200332A patent/OA12257A/en unknown
- 2001-03-26 PL PL35986101A patent/PL359861A1/xx not_active Application Discontinuation
- 2001-03-26 EA EA200200995A patent/EA200200995A1/ru unknown
- 2001-03-26 KR KR1020027014453A patent/KR20030031479A/ko not_active Application Discontinuation
- 2001-03-26 CN CNB018086306A patent/CN1227258C/zh not_active Expired - Fee Related
- 2001-03-26 JP JP2001578446A patent/JP2004516233A/ja not_active Withdrawn
- 2001-03-26 WO PCT/IB2001/000519 patent/WO2001081358A1/en not_active Application Discontinuation
- 2001-03-26 SK SK1488-2002A patent/SK14882002A3/sk unknown
- 2001-03-26 CZ CZ20023409A patent/CZ20023409A3/cs unknown
- 2001-03-26 CA CA002407448A patent/CA2407448A1/en not_active Abandoned
- 2001-03-26 MX MXPA02010586A patent/MXPA02010586A/es unknown
- 2001-04-10 US US09/829,672 patent/US20020019353A1/en not_active Abandoned
- 2001-04-17 PA PA20018515601A patent/PA8515601A1/es unknown
- 2001-04-20 GT GT200100063A patent/GT200100063A/es unknown
- 2001-04-24 UY UY26678A patent/UY26678A1/es not_active Application Discontinuation
- 2001-04-24 PE PE2001000364A patent/PE20011188A1/es not_active Application Discontinuation
- 2001-04-25 AR ARP010101943A patent/AR028041A1/es not_active Application Discontinuation
- 2001-04-26 TN TNTNSN01063A patent/TNSN01063A1/fr unknown
-
2002
- 2002-09-20 IS IS6559A patent/IS6559A/is unknown
- 2002-10-03 BG BG107168A patent/BG107168A/bg unknown
- 2002-10-18 MA MA26874A patent/MA26896A1/fr unknown
- 2002-10-24 ZA ZA200208603A patent/ZA200208603B/xx unknown
- 2002-10-25 NO NO20025134A patent/NO20025134L/no not_active Application Discontinuation
-
2003
- 2003-12-23 US US10/745,748 patent/US20040235759A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| YU78702A (sh) | 2005-11-28 |
| ZA200208603B (en) | 2003-10-24 |
| GT200100063A (es) | 2002-02-18 |
| IL152421A0 (en) | 2003-05-29 |
| CN1429232A (zh) | 2003-07-09 |
| IS6559A (is) | 2002-09-20 |
| MA26896A1 (fr) | 2004-12-20 |
| BR0110382A (pt) | 2003-06-24 |
| AU4269301A (en) | 2001-11-07 |
| AP2002002652A0 (en) | 2002-12-31 |
| AR028041A1 (es) | 2003-04-23 |
| US20040235759A1 (en) | 2004-11-25 |
| SK14882002A3 (en) | 2004-11-03 |
| PA8515601A1 (es) | 2002-07-30 |
| HUP0300585A2 (hu) | 2003-06-28 |
| CN1227258C (zh) | 2005-11-16 |
| KR20030031479A (ko) | 2003-04-21 |
| NO20025134D0 (no) | 2002-10-25 |
| OA12257A (en) | 2003-11-06 |
| UY26678A1 (es) | 2001-12-28 |
| MXPA02010586A (es) | 2003-03-10 |
| PL359861A1 (en) | 2004-09-06 |
| HUP0300585A3 (en) | 2003-09-29 |
| EP1276747A1 (en) | 2003-01-22 |
| CZ20023409A3 (cs) | 2004-01-14 |
| US20020019353A1 (en) | 2002-02-14 |
| CA2407448A1 (en) | 2001-11-01 |
| BG107168A (bg) | 2003-07-31 |
| NO20025134L (no) | 2002-12-19 |
| JP2004516233A (ja) | 2004-06-03 |
| TNSN01063A1 (fr) | 2005-11-10 |
| WO2001081358A1 (en) | 2001-11-01 |
| EA200200995A1 (ru) | 2003-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20011188A1 (es) | El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos | |
| CY1120513T1 (el) | Υψηλης συμπυκνωσης συνθεση μινοξιδιλης | |
| UY26635A1 (es) | Métodos sinérgicos y composiciones para el tratamiento del cáncer | |
| PE20011050A1 (es) | Compuestos antibioticos de azalida | |
| UY25330A1 (es) | Nuevos macrólidos | |
| DE69833684D1 (de) | Antioxidierende stabilisierungssysteme für pharmazeutische formulierungen | |
| KR960701092A (ko) | 아자 사이클로헥사펩타이드 화합물(Aza cyclohexapeptide compounds) | |
| AP2002002674A0 (en) | Clear Aqueous Anaesthetic composition. | |
| EA200500804A1 (ru) | Топические противоинфекционные композиции | |
| BR9812148A (pt) | Derivados de eritromicina 6,9-ligados em ponte | |
| BG104340A (en) | 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity | |
| BR9813317A (pt) | Composto, composição farmacêutica para tratar infecções bacterianas, e, processos para tratar infecções bacterianas, e para preparar um composto | |
| BG104434A (en) | 2-halo-6-o-substituted ketolide derivatives | |
| ES2174921T3 (es) | Inhibidores de la proteasa del vih. | |
| CO5050328A1 (es) | Sistema solvente para la mejor penetracion de compuestos farmaceuticos | |
| AR007021A1 (es) | Derivados de 3-descladinosa-2,3-anhidroeritromicina, procedimientos para su preparacion, compuestos para su exclusivo uso en dichos procedimientosy procedimiento para su preparacion, una composicion farmaceutica para tratar infecciones bacterianas y el uso de estos compuestos para preparar medicamentos | |
| DK1212039T3 (da) | Sammensætning til inhalation omfattende delta-9-tetrahydrocannabinol i et semivandigt oplösningsmiddel | |
| BR0210744A (pt) | Combinação farmacêutica sinergìstica para a prevenção ou tratamento de diabetes | |
| ES2188940T3 (es) | Administracion topica de premafloxacina para el tratamiento de enfermedades bacterianas sistemicas. | |
| BR9708929A (pt) | Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos | |
| CL2004000765A1 (es) | Composicion farmaceutica intranasal que comprende un compuesto derivado de 8,9-dioxo-2,6-diazabiciclo. | |
| EA200001029A1 (ru) | Производные гигромицина | |
| AR031010A1 (es) | Una composicion farmaceutica, util para inhibir el dano celular | |
| WO1999011651A3 (en) | 3-descladinose 6-o-substituded erythromycin derivatives | |
| MXPA01007705A (es) | Derivado de benzamida y medicamento que lo contiene. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |